A possible clue comes from the findings of Herpel et al. [37], who demonstrated a trend toward worse overall survival in a large series of resectable NSCLC patients in the subgroup of patients with relapse whose primary tumor was KIT+ and >3 cm (hazard ratio  = 2.6, p = 0.08). This evidence concerns the gene KIT and non-small cell lung carcinoma.